General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
LPI (LP Information)' newest research report, the "General Anesthesia Drugs Industry Forecast" looks at past sales and reviews total world General Anesthesia Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected General Anesthesia Drugs sales for 2023 through 2029. With General Anesthesia Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world General Anesthesia Drugs industry.
This Insight Report provides a comprehensive analysis of the global General Anesthesia Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on General Anesthesia Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global General Anesthesia Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for General Anesthesia Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global General Anesthesia Drugs.
The global General Anesthesia Drugs market size is projected to grow from US$ 7361.3 million in 2022 to US$ 8931.7 million in 2029; it is expected to grow at a CAGR of 8931.7 from 2023 to 2029.
The major players in global General Anesthesia Drugs market include Astrazeneca, Fresenius-Kabi, B.Braun, etc. The top 3 players occupy about 40% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Propofol is the main type, with a share about 30%. Intravenous Anesthetics is the main application, which holds a share about 70%.
This report presents a comprehensive overview, market shares, and growth opportunities of General Anesthesia Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Propofol
- Etomidate
- Midazolam
- Sevoflurane
- Isoflurane
- Others
Segmentation by application
- Intravenous Anesthetics
- Inhalational Anesthetics
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Astrazeneca
- Fresenius-Kabi
- AbbVie
- Baxter Healthcare
- B.Braun
- Maruishi
- Piramal
- Hikma Pharmaceuticals
- Mylan
- Nhwa
- Hengrui
- Lunan
Key Questions Addressed in this Report
What is the 10-year outlook for the global General Anesthesia Drugs market?
What factors are driving General Anesthesia Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do General Anesthesia Drugs market opportunities vary by end market size?
How does General Anesthesia Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Global General Anesthesia Drugs Market Growth 2023-2029
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global General Anesthesia Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for General Anesthesia Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for General Anesthesia Drugs by Country/Region, 2018, 2022 & 2029
2.2 General Anesthesia Drugs Segment by Type
2.2.1 Propofol
2.2.2 Etomidate
2.2.3 Midazolam
2.2.4 Sevoflurane
2.2.5 Isoflurane
2.2.6 Others
2.3 General Anesthesia Drugs Sales by Type
2.3.1 Global General Anesthesia Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global General Anesthesia Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global General Anesthesia Drugs Sale Price by Type (2018-2023)
2.4 General Anesthesia Drugs Segment by Application
2.4.1 Intravenous Anesthetics
2.4.2 Inhalational Anesthetics
2.5 General Anesthesia Drugs Sales by Application
2.5.1 Global General Anesthesia Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global General Anesthesia Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global General Anesthesia Drugs Sale Price by Application (2018-2023)
3 Global General Anesthesia Drugs by Company
3.1 Global General Anesthesia Drugs Breakdown Data by Company
3.1.1 Global General Anesthesia Drugs Annual Sales by Company (2018-2023)
3.1.2 Global General Anesthesia Drugs Sales Market Share by Company (2018-2023)
3.2 Global General Anesthesia Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global General Anesthesia Drugs Revenue by Company (2018-2023)
3.2.2 Global General Anesthesia Drugs Revenue Market Share by Company (2018-2023)
3.3 Global General Anesthesia Drugs Sale Price by Company
3.4 Key Manufacturers General Anesthesia Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers General Anesthesia Drugs Product Location Distribution
3.4.2 Players General Anesthesia Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for General Anesthesia Drugs by Geographic Region
4.1 World Historic General Anesthesia Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global General Anesthesia Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global General Anesthesia Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic General Anesthesia Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global General Anesthesia Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global General Anesthesia Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas General Anesthesia Drugs Sales Growth
4.4 APAC General Anesthesia Drugs Sales Growth
4.5 Europe General Anesthesia Drugs Sales Growth
4.6 Middle East & Africa General Anesthesia Drugs Sales Growth
5 Americas
5.1 Americas General Anesthesia Drugs Sales by Country
5.1.1 Americas General Anesthesia Drugs Sales by Country (2018-2023)
5.1.2 Americas General Anesthesia Drugs Revenue by Country (2018-2023)
5.2 Americas General Anesthesia Drugs Sales by Type
5.3 Americas General Anesthesia Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC General Anesthesia Drugs Sales by Region
6.1.1 APAC General Anesthesia Drugs Sales by Region (2018-2023)
6.1.2 APAC General Anesthesia Drugs Revenue by Region (2018-2023)
6.2 APAC General Anesthesia Drugs Sales by Type
6.3 APAC General Anesthesia Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe General Anesthesia Drugs by Country
7.1.1 Europe General Anesthesia Drugs Sales by Country (2018-2023)
7.1.2 Europe General Anesthesia Drugs Revenue by Country (2018-2023)
7.2 Europe General Anesthesia Drugs Sales by Type
7.3 Europe General Anesthesia Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa General Anesthesia Drugs by Country
8.1.1 Middle East & Africa General Anesthesia Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa General Anesthesia Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa General Anesthesia Drugs Sales by Type
8.3 Middle East & Africa General Anesthesia Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of General Anesthesia Drugs
10.3 Manufacturing Process Analysis of General Anesthesia Drugs
10.4 Industry Chain Structure of General Anesthesia Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 General Anesthesia Drugs Distributors
11.3 General Anesthesia Drugs Customer
12 World Forecast Review for General Anesthesia Drugs by Geographic Region
12.1 Global General Anesthesia Drugs Market Size Forecast by Region
12.1.1 Global General Anesthesia Drugs Forecast by Region (2024-2029)
12.1.2 Global General Anesthesia Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global General Anesthesia Drugs Forecast by Type
12.7 Global General Anesthesia Drugs Forecast by Application
13 Key Players Analysis
13.1 Astrazeneca
13.1.1 Astrazeneca Company Information
13.1.2 Astrazeneca General Anesthesia Drugs Product Portfolios and Specifications
13.1.3 Astrazeneca General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Astrazeneca Main Business Overview
13.1.5 Astrazeneca Latest Developments
13.2 Fresenius-Kabi
13.2.1 Fresenius-Kabi Company Information
13.2.2 Fresenius-Kabi General Anesthesia Drugs Product Portfolios and Specifications
13.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Fresenius-Kabi Main Business Overview
13.2.5 Fresenius-Kabi Latest Developments
13.3 AbbVie
13.3.1 AbbVie Company Information
13.3.2 AbbVie General Anesthesia Drugs Product Portfolios and Specifications
13.3.3 AbbVie General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AbbVie Main Business Overview
13.3.5 AbbVie Latest Developments
13.4 Baxter Healthcare
13.4.1 Baxter Healthcare Company Information
13.4.2 Baxter Healthcare General Anesthesia Drugs Product Portfolios and Specifications
13.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Baxter Healthcare Main Business Overview
13.4.5 Baxter Healthcare Latest Developments
13.5 B.Braun
13.5.1 B.Braun Company Information
13.5.2 B.Braun General Anesthesia Drugs Product Portfolios and Specifications
13.5.3 B.Braun General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 B.Braun Main Business Overview
13.5.5 B.Braun Latest Developments
13.6 Maruishi
13.6.1 Maruishi Company Information
13.6.2 Maruishi General Anesthesia Drugs Product Portfolios and Specifications
13.6.3 Maruishi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Maruishi Main Business Overview
13.6.5 Maruishi Latest Developments
13.7 Piramal
13.7.1 Piramal Company Information
13.7.2 Piramal General Anesthesia Drugs Product Portfolios and Specifications
13.7.3 Piramal General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Piramal Main Business Overview
13.7.5 Piramal Latest Developments
13.8 Hikma Pharmaceuticals
13.8.1 Hikma Pharmaceuticals Company Information
13.8.2 Hikma Pharmaceuticals General Anesthesia Drugs Product Portfolios and Specifications
13.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hikma Pharmaceuticals Main Business Overview
13.8.5 Hikma Pharmaceuticals Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan General Anesthesia Drugs Product Portfolios and Specifications
13.9.3 Mylan General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Nhwa
13.10.1 Nhwa Company Information
13.10.2 Nhwa General Anesthesia Drugs Product Portfolios and Specifications
13.10.3 Nhwa General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nhwa Main Business Overview
13.10.5 Nhwa Latest Developments
13.11 Hengrui
13.11.1 Hengrui Company Information
13.11.2 Hengrui General Anesthesia Drugs Product Portfolios and Specifications
13.11.3 Hengrui General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hengrui Main Business Overview
13.11.5 Hengrui Latest Developments
13.12 Lunan
13.12.1 Lunan Company Information
13.12.2 Lunan General Anesthesia Drugs Product Portfolios and Specifications
13.12.3 Lunan General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Lunan Main Business Overview
13.12.5 Lunan Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. General Anesthesia Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. General Anesthesia Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Propofol
Table 4. Major Players of Etomidate
Table 5. Major Players of Midazolam
Table 6. Major Players of Sevoflurane
Table 7. Major Players of Isoflurane
Table 8. Major Players of Others
Table 9. Global General Anesthesia Drugs Sales by Type (2018-2023) & (K Units)
Table 10. Global General Anesthesia Drugs Sales Market Share by Type (2018-2023)
Table 11. Global General Anesthesia Drugs Revenue by Type (2018-2023) & ($ million)
Table 12. Global General Anesthesia Drugs Revenue Market Share by Type (2018-2023)
Table 13. Global General Anesthesia Drugs Sale Price by Type (2018-2023) & (USD/Unit)
Table 14. Global General Anesthesia Drugs Sales by Application (2018-2023) & (K Units)
Table 15. Global General Anesthesia Drugs Sales Market Share by Application (2018-2023)
Table 16. Global General Anesthesia Drugs Revenue by Application (2018-2023)
Table 17. Global General Anesthesia Drugs Revenue Market Share by Application (2018-2023)
Table 18. Global General Anesthesia Drugs Sale Price by Application (2018-2023) & (USD/Unit)
Table 19. Global General Anesthesia Drugs Sales by Company (2018-2023) & (K Units)
Table 20. Global General Anesthesia Drugs Sales Market Share by Company (2018-2023)
Table 21. Global General Anesthesia Drugs Revenue by Company (2018-2023) ($ Millions)
Table 22. Global General Anesthesia Drugs Revenue Market Share by Company (2018-2023)
Table 23. Global General Anesthesia Drugs Sale Price by Company (2018-2023) & (USD/Unit)
Table 24. Key Manufacturers General Anesthesia Drugs Producing Area Distribution and Sales Area
Table 25. Players General Anesthesia Drugs Products Offered
Table 26. General Anesthesia Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global General Anesthesia Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global General Anesthesia Drugs Sales Market Share Geographic Region (2018-2023)
Table 31. Global General Anesthesia Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global General Anesthesia Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global General Anesthesia Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global General Anesthesia Drugs Sales Market Share by Country/Region (2018-2023)
Table 35. Global General Anesthesia Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global General Anesthesia Drugs Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas General Anesthesia Drugs Sales by Country (2018-2023) & (K Units)
Table 38. Americas General Anesthesia Drugs Sales Market Share by Country (2018-2023)
Table 39. Americas General Anesthesia Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas General Anesthesia Drugs Revenue Market Share by Country (2018-2023)
Table 41. Americas General Anesthesia Drugs Sales by Type (2018-2023) & (K Units)
Table 42. Americas General Anesthesia Drugs Sales by Application (2018-2023) & (K Units)
Table 43. APAC General Anesthesia Drugs Sales by Region (2018-2023) & (K Units)
Table 44. APAC General Anesthesia Drugs Sales Market Share by Region (2018-2023)
Table 45. APAC General Anesthesia Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC General Anesthesia Drugs Revenue Market Share by Region (2018-2023)
Table 47. APAC General Anesthesia Drugs Sales by Type (2018-2023) & (K Units)
Table 48. APAC General Anesthesia Drugs Sales by Application (2018-2023) & (K Units)
Table 49. Europe General Anesthesia Drugs Sales by Country (2018-2023) & (K Units)
Table 50. Europe General Anesthesia Drugs Sales Market Share by Country (2018-2023)
Table 51. Europe General Anesthesia Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe General Anesthesia Drugs Revenue Market Share by Country (2018-2023)
Table 53. Europe General Anesthesia Drugs Sales by Type (2018-2023) & (K Units)
Table 54. Europe General Anesthesia Drugs Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa General Anesthesia Drugs Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa General Anesthesia Drugs Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa General Anesthesia Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa General Anesthesia Drugs Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa General Anesthesia Drugs Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa General Anesthesia Drugs Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of General Anesthesia Drugs
Table 62. Key Market Challenges & Risks of General Anesthesia Drugs
Table 63. Key Industry Trends of General Anesthesia Drugs
Table 64. General Anesthesia Drugs Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. General Anesthesia Drugs Distributors List
Table 67. General Anesthesia Drugs Customer List
Table 68. Global General Anesthesia Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global General Anesthesia Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas General Anesthesia Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas General Anesthesia Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC General Anesthesia Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC General Anesthesia Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe General Anesthesia Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe General Anesthesia Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa General Anesthesia Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa General Anesthesia Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global General Anesthesia Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global General Anesthesia Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global General Anesthesia Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global General Anesthesia Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Astrazeneca Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Astrazeneca General Anesthesia Drugs Product Portfolios and Specifications
Table 84. Astrazeneca General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 85. Astrazeneca Main Business
Table 86. Astrazeneca Latest Developments
Table 87. Fresenius-Kabi Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Fresenius-Kabi General Anesthesia Drugs Product Portfolios and Specifications
Table 89. Fresenius-Kabi General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 90. Fresenius-Kabi Main Business
Table 91. Fresenius-Kabi Latest Developments
Table 92. AbbVie Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. AbbVie General Anesthesia Drugs Product Portfolios and Specifications
Table 94. AbbVie General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 95. AbbVie Main Business
Table 96. AbbVie Latest Developments
Table 97. Baxter Healthcare Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Baxter Healthcare General Anesthesia Drugs Product Portfolios and Specifications
Table 99. Baxter Healthcare General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 100. Baxter Healthcare Main Business
Table 101. Baxter Healthcare Latest Developments
Table 102. B.Braun Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. B.Braun General Anesthesia Drugs Product Portfolios and Specifications
Table 104. B.Braun General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 105. B.Braun Main Business
Table 106. B.Braun Latest Developments
Table 107. Maruishi Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Maruishi General Anesthesia Drugs Product Portfolios and Specifications
Table 109. Maruishi General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Maruishi Main Business
Table 111. Maruishi Latest Developments
Table 112. Piramal Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Piramal General Anesthesia Drugs Product Portfolios and Specifications
Table 114. Piramal General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Piramal Main Business
Table 116. Piramal Latest Developments
Table 117. Hikma Pharmaceuticals Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Hikma Pharmaceuticals General Anesthesia Drugs Product Portfolios and Specifications
Table 119. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Hikma Pharmaceuticals Main Business
Table 121. Hikma Pharmaceuticals Latest Developments
Table 122. Mylan Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Mylan General Anesthesia Drugs Product Portfolios and Specifications
Table 124. Mylan General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Mylan Main Business
Table 126. Mylan Latest Developments
Table 127. Nhwa Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Nhwa General Anesthesia Drugs Product Portfolios and Specifications
Table 129. Nhwa General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Nhwa Main Business
Table 131. Nhwa Latest Developments
Table 132. Hengrui Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Hengrui General Anesthesia Drugs Product Portfolios and Specifications
Table 134. Hengrui General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Hengrui Main Business
Table 136. Hengrui Latest Developments
Table 137. Lunan Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Lunan General Anesthesia Drugs Product Portfolios and Specifications
Table 139. Lunan General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. Lunan Main Business
Table 141. Lunan Latest Developments
List of Figures
Figure 1. Picture of General Anesthesia Drugs
Figure 2. General Anesthesia Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global General Anesthesia Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global General Anesthesia Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. General Anesthesia Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Propofol
Figure 10. Product Picture of Etomidate
Figure 11. Product Picture of Midazolam
Figure 12. Product Picture of Sevoflurane
Figure 13. Product Picture of Isoflurane
Figure 14. Product Picture of Others
Figure 15. Global General Anesthesia Drugs Sales Market Share by Type in 2022
Figure 16. Global General Anesthesia Drugs Revenue Market Share by Type (2018-2023)
Figure 17. General Anesthesia Drugs Consumed in Intravenous Anesthetics
Figure 18. Global General Anesthesia Drugs Market: Intravenous Anesthetics (2018-2023) & (K Units)
Figure 19. General Anesthesia Drugs Consumed in Inhalational Anesthetics
Figure 20. Global General Anesthesia Drugs Market: Inhalational Anesthetics (2018-2023) & (K Units)
Figure 21. Global General Anesthesia Drugs Sales Market Share by Application (2022)
Figure 22. Global General Anesthesia Drugs Revenue Market Share by Application in 2022
Figure 23. General Anesthesia Drugs Sales Market by Company in 2022 (K Units)
Figure 24. Global General Anesthesia Drugs Sales Market Share by Company in 2022
Figure 25. General Anesthesia Drugs Revenue Market by Company in 2022 ($ Million)
Figure 26. Global General Anesthesia Drugs Revenue Market Share by Company in 2022
Figure 27. Global General Anesthesia Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global General Anesthesia Drugs Revenue Market Share by Geographic Region in 2022
Figure 29. Americas General Anesthesia Drugs Sales 2018-2023 (K Units)
Figure 30. Americas General Anesthesia Drugs Revenue 2018-2023 ($ Millions)
Figure 31. APAC General Anesthesia Drugs Sales 2018-2023 (K Units)
Figure 32. APAC General Anesthesia Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Europe General Anesthesia Drugs Sales 2018-2023 (K Units)
Figure 34. Europe General Anesthesia Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa General Anesthesia Drugs Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa General Anesthesia Drugs Revenue 2018-2023 ($ Millions)
Figure 37. Americas General Anesthesia Drugs Sales Market Share by Country in 2022
Figure 38. Americas General Anesthesia Drugs Revenue Market Share by Country in 2022
Figure 39. Americas General Anesthesia Drugs Sales Market Share by Type (2018-2023)
Figure 40. Americas General Anesthesia Drugs Sales Market Share by Application (2018-2023)
Figure 41. United States General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC General Anesthesia Drugs Sales Market Share by Region in 2022
Figure 46. APAC General Anesthesia Drugs Revenue Market Share by Regions in 2022
Figure 47. APAC General Anesthesia Drugs Sales Market Share by Type (2018-2023)
Figure 48. APAC General Anesthesia Drugs Sales Market Share by Application (2018-2023)
Figure 49. China General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. India General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe General Anesthesia Drugs Sales Market Share by Country in 2022
Figure 57. Europe General Anesthesia Drugs Revenue Market Share by Country in 2022
Figure 58. Europe General Anesthesia Drugs Sales Market Share by Type (2018-2023)
Figure 59. Europe General Anesthesia Drugs Sales Market Share by Application (2018-2023)
Figure 60. Germany General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. France General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa General Anesthesia Drugs Sales Market Share by Country in 2022
Figure 66. Middle East & Africa General Anesthesia Drugs Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa General Anesthesia Drugs Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa General Anesthesia Drugs Sales Market Share by Application (2018-2023)
Figure 69. Egypt General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country General Anesthesia Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of General Anesthesia Drugs in 2022
Figure 75. Manufacturing Process Analysis of General Anesthesia Drugs
Figure 76. Industry Chain Structure of General Anesthesia Drugs
Figure 77. Channels of Distribution
Figure 78. Global General Anesthesia Drugs Sales Market Forecast by Region (2024-2029)
Figure 79. Global General Anesthesia Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global General Anesthesia Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global General Anesthesia Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global General Anesthesia Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global General Anesthesia Drugs Revenue Market Share Forecast by Application (2024-2029)
Global Sevoflurane Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 90
According to our LPI (LP Information) latest study, the global Sevoflurane market size was valued at US$ 1293.8 million in 2023. With growing demand in downstream market, the Sevoflurane is forecast to a readjusted size of US$ 1247.6 million by 2030 with a CAGR of -0.5% during review period.
The research report highlights the growth potential of the global Sevoflurane market. Sevoflurane are expected to show stable growth in the future market. However, product differentiation, reducing c......
Global Remifentanil Hydrochloride Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Remifentanil Hydrochloride market size was valued at US$ million in 2023. With growing demand in downstream market, the Remifentanil Hydrochloride is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Remifentanil Hydrochloride market. Remifentanil Hydrochloride are expected to show stable growth in the future market. How......
Global General Anesthesia Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 111
According to our LPI (LP Information) latest study, the global General Anesthesia Drugs market size was valued at US$ 3840.3 million in 2023. With growing demand in downstream market, the General Anesthesia Drugs is forecast to a readjusted size of US$ 4929.3 million by 2030 with a CAGR of 3.6% during review period.
The research report highlights the growth potential of the global General Anesthesia Drugs market. General Anesthesia Drugs are expected to show stable growth in the future m......
Global Sevoflurane Source Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 90
According to our LPI (LP Information) latest study, the global Sevoflurane Source market size was valued at US$ 1192.7 million in 2023. With growing demand in downstream market, the Sevoflurane Source is forecast to a readjusted size of US$ 1509.6 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Sevoflurane Source market. Sevoflurane Source are expected to show stable growth in the future market. However, product ......
Global Anesthesia Drugs Market Research Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 2680 Onwards Pages: 166
Anesthesia is the practice of administering medicines that block the feeling of pain or other sensations to allow medical or surgical operations to take place without causing undue distress or discomfort.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while takin......
Global Anesthesia Drugs Professional Survey Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 3280 Onwards Pages: 108
Anesthesia is the practice of administering medicines that block the feeling of pain or other sensations to allow medical or surgical operations to take place without causing undue distress or discomfort.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while takin......
Global Sevoflurane Professional Survey Report 2023, Forecast to 2028
Published: 22-Nov-2023 Price: US 3280 Onwards Pages: 109
Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. T......
Global Sevoflurane Market Research Report 2023, Forecast to 2028
Published: 22-Nov-2023 Price: US 2680 Onwards Pages: 132
Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. T......
Global Sevoflurane Source Market Research Report 2023, Forecast to 2028
Published: 14-Nov-2023 Price: US 2680 Onwards Pages: 137
Sevoflurane Source is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerg......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
